Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine
NCT01345721
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
205
Enrollment
INDUSTRY
Sponsor class
Conditions
Meningococcal Disease
Interventions
BIOLOGICAL:
MenACWY-CRM
Sponsor
Novartis Vaccines